VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 58 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $20,000 | – | 10,205 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 256,244 | $3,203,000 | 0.84% |
| Perceptive Advisors | 3,610,412 | $45,130,000 | 0.66% |
| Orbimed Advisors | 1,479,733 | $18,497,000 | 0.20% |
| Fosun International Ltd | 282,408 | $3,530,000 | 0.18% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 728,236 | $9,103,000 | 0.14% |
| SteelPeak Wealth, LLC | 133,161 | $1,665,000 | 0.11% |
| HighVista Strategies LLC | 10,944 | $137,000 | 0.09% |
| Capital Investment Advisory Services, LLC | 15,125 | $189,000 | 0.02% |
| MML INVESTORS SERVICES, LLC | 44,875 | $561,000 | 0.00% |
| BECK MACK & OLIVER LLC | 10,000 | $125,000 | 0.00% |